Additionally, the impact of QZD on immune-related pathways, such as Th17 cell differentiation and C-type lectin receptor signaling, indicates a potential role in modulating the tumor microenvironment to counteract disease progression and immune evasion. Here, CLEC4D is linked to neoplasm.